These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 10365385)
41. [The clinical characteristics and prognostic analysis of gastric mucosa-associated lymphoid tissue lymphoma of 103 cases]. Li XW; Xia B; Guo Q; Jin X; Yu Y; Zhao ZG; Wang XF; Wang YF; Zhang YZ Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):805-9. PubMed ID: 23384898 [TBL] [Abstract][Full Text] [Related]
42. Pretreatment risk factors for overall survival in patients with gastrointestinal and non-gastrointestinal mucosa associated lymphoid tissue lymphomas. Virijevic M; Perunicic-Jovanovic M; Djunic I; Novkovic A; Mihaljevic B J BUON; 2014; 19(1):178-82. PubMed ID: 24659661 [TBL] [Abstract][Full Text] [Related]
43. Clinicopathological aspects of mucosa-associated lymphoid tissue (MALT) lymphoma of the parotid gland: a retrospective single-center analysis of 28 cases. Troch M; Formanek M; Streubel B; Müllauer L; Chott A; Raderer M Head Neck; 2011 Jun; 33(6):763-7. PubMed ID: 20737498 [TBL] [Abstract][Full Text] [Related]
44. Primary salivary gland lymphoma: a clinicopathologic study of 23 cases in Taiwan. Dunn P; Kuo TT; Shih LY; Lin TL; Wang PN; Kuo MC; Tang CC Acta Haematol; 2004; 112(4):203-8. PubMed ID: 15564732 [TBL] [Abstract][Full Text] [Related]
45. Extranodal non-hodgkin lymphomas of the oral cavity and maxillofacial region: a clinical study of 58 cases and review of the literature. Triantafillidou K; Dimitrakopoulos J; Iordanidis F; Gkagkalis A J Oral Maxillofac Surg; 2012 Dec; 70(12):2776-85. PubMed ID: 22494508 [TBL] [Abstract][Full Text] [Related]
46. Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma study. Oh SY; Kim WS; Kim JS; Kim SJ; Lee S; Lee DH; Kang HJ; Song MK; Kim HJ; Kwon JH; Kwak JY; Park BB; Do YR; Jeong SH; Suh C Acta Haematol; 2012; 127(2):100-4. PubMed ID: 22178776 [TBL] [Abstract][Full Text] [Related]
47. Clinical study of mucosa-associated lymphoid tissue lymphomas of the head and neck. Hosokawa S; Okamura J; Takizawa Y; Takahashi G; Hosokawa K; Mineta H J Laryngol Otol; 2012 Mar; 126(3):271-5. PubMed ID: 21867583 [TBL] [Abstract][Full Text] [Related]
48. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue arising in the extracranial head and neck region: a high rate of dissemination and disease recurrence. Suh C; Huh J; Roh JL Oral Oncol; 2008 Oct; 44(10):949-55. PubMed ID: 18234544 [TBL] [Abstract][Full Text] [Related]
49. Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24553 patients with Hashimoto's disease. Watanabe N; Noh JY; Narimatsu H; Takeuchi K; Yamaguchi T; Kameyama K; Kobayashi K; Kami M; Kubo A; Kunii Y; Shimizu T; Mukasa K; Otsuka F; Miyara A; Minagawa A; Ito K; Ito K Br J Haematol; 2011 Apr; 153(2):236-43. PubMed ID: 21371004 [TBL] [Abstract][Full Text] [Related]
51. [Treatment of MALT lymphoma of the digestive tract]. Hudecek J; Paceková M; Michalová R; Szépe P; Adamkov M; Hyrdel R; Plank L; Kubisz P Vnitr Lek; 1997 May; 43(5):302-6. PubMed ID: 9601853 [TBL] [Abstract][Full Text] [Related]
52. [Rituximab therapy for systemic manifestations and MALT lymphomas of the parotid gland in Sjögren's disease: preliminary data]. Logvinenko OA; Vasil'ev VI; Sedyshev SKh; Safonova TN; Rodionova EB; Kokosadze NV; Aleksandrova EN; Cherkasova MV; Radenska-Lopovok SG; Nasonov EL Ter Arkh; 2012; 84(12):88-96. PubMed ID: 23479998 [TBL] [Abstract][Full Text] [Related]
53. What are the criteria for distinguishing MALT from non-MALT lymphoma at extranodal sites? Harris NL; Isaacson PG Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S126-32. PubMed ID: 9894477 [TBL] [Abstract][Full Text] [Related]
54. Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients. Bailey EM; Ferry JA; Harris NL; Mihm MC; Jacobson JO; Duncan LM Am J Surg Pathol; 1996 Aug; 20(8):1011-23. PubMed ID: 8712288 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of the clinical characteristics and prognostic factors of gastrointestinal mucosa-associated lymphoid tissue (MALT) lymphoma. Xu X; Wang Z; Yu Y; Wang Y; Zhang L; Sun B; Da W; Zhang Y J Gastroenterol Hepatol; 2014 Sep; 29(9):1678-84. PubMed ID: 24730769 [TBL] [Abstract][Full Text] [Related]
57. [Clinical features and prognosis of mucosa-associated lymphoid tissue lymphoma]. Tian L; Zhang C; Liu W; Wang X; Zheng W; Xie Y; Lin N; Ying Z; Ping L; Deng L; Song Y; Zhu J Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):759-62. PubMed ID: 24844960 [TBL] [Abstract][Full Text] [Related]
58. Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41). Jackson AE; Mian M; Kalpadakis C; Pangalis GA; Stathis A; Porro E; Conconi A; Cortelazzo S; Gaidano G; Lopez Guillermo A; Johnson PW; Martelli M; Martinelli G; Thieblemont C; McPhail ED; Copie-Bergman C; Pileri SA; Jack A; Campo E; Mazzucchelli L; Ristow K; Habermann TM; Cavalli F; Nowakowski GS; Zucca E Oncologist; 2015 Oct; 20(10):1149-53. PubMed ID: 26268740 [TBL] [Abstract][Full Text] [Related]
60. Retrospective comparison of the effectiveness of various treatment modalities of extragastric MALT lymphoma: a single-center analysis. Wöhrer S; Kiesewetter B; Fischbach J; Müllauer L; Troch M; Lukas J; Mayerhoefer ME; Raderer M Ann Hematol; 2014 Aug; 93(8):1287-95. PubMed ID: 24633660 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]